Lymphocyte activation gene-3 (LAG-3) and cluster of differentiation-155 (CD-155) expression by immunohistochemistry do not predict response and survival in non-small lung cancer (NSCLC) patients treated with second-line nivolumab treatment
JOURNAL OF THORACIC ONCOLOGY, sa.3, 2025 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Özet
- Basım Tarihi: 2025
- Dergi Adı: JOURNAL OF THORACIC ONCOLOGY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, MEDLINE
- Hacettepe Üniversitesi Adresli: Evet